arrow_back Trending Legislation
Share share

Tracking Xylazine (Tranq) Sources: New Requirements for Narcotics Report.

This bill aims to enhance public safety by addressing the opioid crisis. It requires the U.S. government to identify and report on countries that are significant sources of xylazine—a dangerous substance often mixed with illicit drugs like fentanyl. Better tracking is intended to curb the supply of this poison, which contributes to fatal overdoses.
Key points
Mandates tracking the international sources of xylazine (Tranq), a substance increasing the lethality of illicit drugs.
Information on countries producing xylazine will be included in the annual International Narcotics Control Strategy Report.
The goal is to reduce the flow of xylazine into the U.S., improving public safety and health.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
STOP TRANQ Act
Print number: HR 9347
Sponsor: Rep. Fong, Vince [R-CA-20]
Process start date: 2024-08-13
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Tracking Xylazine (Tranq) Sources: New Requirements for Narcotics Report.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 9347.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-08-13.

What are the main provisions?

Key points include:

  • Mandates tracking the international sources of xylazine (Tranq), a substance increasing the lethality of illicit drugs.
  • Information on countries producing xylazine will be included in the annual International Narcotics Control Strategy Report.
  • The goal is to reduce the flow of xylazine into the U.S., improving public safety and health.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Fong, Vince [R-CA-20].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Foreign Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of HR 9347

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Security Health